Author | Loretta J. Nastoupil, MD

Articles

POINT: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?

August 15, 2018

Balancing the goal of obtaining a durable remission and that of avoiding a negative impact on quality of life argues against the routine use of chemotherapy in follicular lymphoma.

Routine Use of Maintenance Therapy in Follicular Lymphoma: The Strategy Is Effective, Raising the Question, ‘What Is the Most Important Measure of Success in the Current Era?’

September 15, 2014

The rationale for maintenance therapy in indolent non-Hodgkin lymphoma was derived from historical data suggesting that despite robust response rates to standard therapy, most patients eventually relapse and disease-free intervals become progressively shorter.

Novel Therapies in Mantle Cell Lymphoma: A Pathway to Chemotherapy-Free Strategies

October 15, 2013

This review will cover innovative therapeutic approaches in relapsed or refractory MCL, many of which have the potential to alter treatment paradigms toward the development of strategies that do not involve conventional chemotherapy agents.

Diffuse Large B-Cell Lymphoma: Current Treatment Approaches

May 15, 2012

This article examines clinical and biological features of DLBCL patients with poor outcomes, and reviews recent studies addressing alternatives to standard front-line management strategies together with unresolved questions.